Ignite Creation Date:
2025-12-24 @ 10:37 PM
Ignite Modification Date:
2026-01-31 @ 7:43 AM
Study NCT ID:
NCT06873035
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2025-12-15
First Post:
2025-02-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Interventional Study of Infigratinib in Children With Hypochondroplasia
Sponsor:
QED Therapeutics, a BridgeBio company
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hypochondroplasia | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | skeletal dysplasia | View |
| None | endochondral ossification | View |
| None | hypochondroplasia | View |
| None | HCH | View |
| None | shortened proximal limbs | View |
| None | fibroblast growth factor receptor 3 | View |
| None | FGFR3 | View |
| None | endochondral bone formation | View |
| None | disproportionate short stature | View |
| None | quality of life | View |
| None | dwarfism | View |
| None | bone diseases | View |
| None | musculoskeletal diseases | View |
| None | osteochondrodysplasia | View |
| None | functional abilities | View |
| None | annualized growth velocity | View |
| None | annualized height velocity | View |
| None | growth | View |
| None | genetic diseases | View |
| None | congenital | View |
| None | AHV | View |
| None | AGV | View |
| None | Pathogenic variants | View |